Skip to main content

arexvy

arexvy: 1 clinical trial tracked.

arexvy evidence translation

What we can confirm

1 tracked trial

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about arexvy, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 1 study sponsors

Related indications

Clinical Trial Registry Records (1)

A Phase 1 Randomized, Placebo- and Active-controlled, Observer-blind Study in Older Adults With Run-in in Young Adults to Evaluate the Safety, Reactogenicity, and Immunogenicity of Four Dose Levels of VXB-241, A Molecular Clamp Stabilized Prefusion F Glycoprotein Subunit Bivalent Vaccine Candidate for the Prevention of Lower Respiratory Tract Disease Caused by Respiratory Syncytial Virus (RSV) And Human Metapneumovirus (HMPV)

NCT06556147Registry updated 2026-05-20·Phase 1·SNY
Active, not recruiting

Primary endpoint: Proportion of Older Adult Participants With 1 or More Unsolicited AEs

InterventionalRandomizeddouble144 targetStarted 2024-08Completion 2027-054 sites · AustraliaSanofi